These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 20922271)

  • 1. In vitro modulation of Bcl-2 levels in small cell lung cancer cells: effects on cell viability.
    Santos AO; Pereira JP; Pedroso de Lima MC; Simões S; Moreira JN
    Braz J Med Biol Res; 2010 Oct; 43(10):1001-9. PubMed ID: 20922271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of apoptosis in small-cell lung cancer cells by an antisense oligodeoxynucleotide targeting the Bcl-2 coding sequence.
    Ziegler A; Luedke GH; Fabbro D; Altmann KH; Stahel RA; Zangemeister-Wittke U
    J Natl Cancer Inst; 1997 Jul; 89(14):1027-36. PubMed ID: 9230884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activity of a novel bcl-2/bcl-xL-bispecific antisense oligonucleotide against tumors of diverse histologic origins.
    Gautschi O; Tschopp S; Olie RA; Leech SH; Simões-Wüst AP; Ziegler A; Baumann B; Odermatt B; Hall J; Stahel RA; Zangemeister-Wittke U
    J Natl Cancer Inst; 2001 Mar; 93(6):463-71. PubMed ID: 11259472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Role and clinical significance of RLIP76 in regulation of multi-drug resistance of small cell lung cancer].
    Haixia P; Yifeng B; Honglin H
    Zhonghua Zhong Liu Za Zhi; 2015 Apr; 37(4):266-71. PubMed ID: 26462890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-receptor tyrosine kinase Etk regulation of drug resistance in small-cell lung cancer.
    Guo L; Zhou Y; Sun Y; Zhang F
    Eur J Cancer; 2010 Feb; 46(3):636-41. PubMed ID: 20004564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucocorticoid receptor-mediated apoptosis in small-cell lung cancer requires interaction with BCL2.
    Schlossmacher G; Platt E; Davies A; Meredith S; White A
    Endocr Relat Cancer; 2013 Dec; 20(6):785-95. PubMed ID: 24036132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bcl-2 downregulation sensitizes nonsmall cell lung cancer cells to cisplatin, but not to docetaxel.
    Losert D; Pratscher B; Soutschek J; Geick A; Vornlocher HP; Müller M; Wacheck V
    Anticancer Drugs; 2007 Aug; 18(7):755-61. PubMed ID: 17581297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cisplatin and photodynamic therapy exert synergistic inhibitory effects on small-cell lung cancer cell viability and xenograft tumor growth.
    Cheng YS; Peng YB; Yao M; Teng JP; Ni D; Zhu ZJ; Zhuang BF; Yang ZY
    Biochem Biophys Res Commun; 2017 Jun; 487(3):567-572. PubMed ID: 28431928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Role of SALL4 in regulating multi-drug resistance of small cell lung cancer and its clinical significance].
    Liu H; Bai Y; Wang W; Guo L
    Zhonghua Bing Li Xue Za Zhi; 2014 Sep; 43(9):604-8. PubMed ID: 25471501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting ROR1/BCL2 combination targeted therapy of small cell carcinoma of the lung.
    Wang WZ; Shilo K; Amann JM; Shulman A; Hojjat-Farsangi M; Mellstedt H; Schultz J; Croce CM; Carbone DP
    Cell Death Dis; 2021 Jun; 12(6):577. PubMed ID: 34088900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HSP90 inhibitor (NVP-AUY922) enhances the anti-cancer effect of BCL-2 inhibitor (ABT-737) in small cell lung cancer expressing BCL-2.
    Yang H; Lee MH; Park I; Jeon H; Choi J; Seo S; Kim SW; Koh GY; Park KS; Lee DH
    Cancer Lett; 2017 Dec; 411():19-26. PubMed ID: 28987383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bcl-XL small interfering RNA sensitizes cisplatin-resistant human lung adenocarcinoma cells.
    Lei X; Huang Z; Zhong M; Zhu B; Tang S; Liao D
    Acta Biochim Biophys Sin (Shanghai); 2007 May; 39(5):344-50. PubMed ID: 17492131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The effect of Bcl-2 gene silencing on the sensitivity of cell line A549 to chemotherapeutic drugs].
    Wang JQ; Du ZW; Gao XF; Wu M; Zhang YC; Pan Y; Wang Q; Zhang GZ
    Zhonghua Jie He He Hu Xi Za Zhi; 2013 Mar; 36(3):191-7. PubMed ID: 23856142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous evaluation of viability and Bcl-2 in small-cell lung cancer.
    Santos A; Sarmento-Ribeiro AB; de Lima MC; Simões S; Moreira JN
    Cytometry A; 2008 Dec; 73A(12):1165-72. PubMed ID: 18785266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 'Seed' analysis of off-target siRNAs reveals an essential role of Mcl-1 in resistance to the small-molecule Bcl-2/Bcl-XL inhibitor ABT-737.
    Lin X; Morgan-Lappe S; Huang X; Li L; Zakula DM; Vernetti LA; Fesik SW; Shen Y
    Oncogene; 2007 Jun; 26(27):3972-9. PubMed ID: 17173063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dolastatin 15 induces apoptosis and BCL-2 phosphorylation in small cell lung cancer cell lines.
    Ali MA; Rosati R; Pettit GR; Kalemkerian GP
    Anticancer Res; 1998; 18(2A):1021-6. PubMed ID: 9615758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. G3139 and other CpG-containing immunostimulatory phosphorothioate oligodeoxynucleotides are potent suppressors of the growth of human tumor xenografts in nude mice.
    Gekeler V; Gimmnich P; Hofmann HP; Grebe C; Römmele M; Leja A; Baudler M; Benimetskaya L; Gonser B; Pieles U; Maier T; Wagner T; Sanders K; Beck JF; Hanauer G; Stein CA
    Oligonucleotides; 2006; 16(1):83-93. PubMed ID: 16584297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of Bcl-2 family members on the cellular response of small-cell lung cancer cell lines to ABT-737.
    Tahir SK; Yang X; Anderson MG; Morgan-Lappe SE; Sarthy AV; Chen J; Warner RB; Ng SC; Fesik SW; Elmore SW; Rosenberg SH; Tse C
    Cancer Res; 2007 Feb; 67(3):1176-83. PubMed ID: 17283153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Role of homeobox gene A5 in multidrug resistance of human small cell lung cancer cells].
    Xiao F; Chen Z; Zeng X; Bai Y; Guo L; Li Y
    Nan Fang Yi Ke Da Xue Xue Bao; 2013 Nov; 33(11):1665-8. PubMed ID: 24273274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effective growth-suppressive activity of maternal embryonic leucine-zipper kinase (MELK) inhibitor against small cell lung cancer.
    Inoue H; Kato T; Olugbile S; Tamura K; Chung S; Miyamoto T; Matsuo Y; Salgia R; Nakamura Y; Park JH
    Oncotarget; 2016 Mar; 7(12):13621-33. PubMed ID: 26871945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.